News & Media Catch up with our latest releases here. Filter Article 55 Podcast 3 Video 26 Article, Video Rob Bennett 16/08/2024 Article, Video Rob Bennett 16/08/2024 09/05 OCT Reveal Plans to Delist as Stocks Struggle Read More Video Rob Bennett 01/12/2023 Video Rob Bennett 01/12/2023 Oxford Cannabinoid Technologies Appoint Dr Tim Corn, CMO as Exec. Director Read More Article, Video Rob Bennett 20/11/2023 Article, Video Rob Bennett 20/11/2023 Oxford Cannabinoid Technologies strengthens board with CMO Dr. Tim Corn Read More Article, Video Rob Bennett 31/10/2023 Article, Video Rob Bennett 31/10/2023 Oxford Cannabinoid Technologies – executive interview Read More Article, Video Rob Bennett 10/10/2023 Article, Video Rob Bennett 10/10/2023 Oxford Cannabinoid Technologies CEO says objective "absolutely met" in lead asset trial Read More Video, Article Rob Bennett 25/09/2023 Video, Article Rob Bennett 25/09/2023 Oxford Cannabinoid Technologies reports no adverse events in OCT461201 trial Read More Video Rob Bennett 25/09/2023 Video Rob Bennett 25/09/2023 Oxford Canabinoid Tech. Complete Phase 1 Clinical Trials on Programme 1 for CIPN Treatment Read More Video Rob Bennett 20/08/2023 Video Rob Bennett 20/08/2023 OCT features on Research Talks with Alan Green Read More Video Rob Bennett 27/07/2023 Video Rob Bennett 27/07/2023 Clarissa Sowemimo-Coker CEO: OCTP Achieves Milestone in Phase One Clinical Trial Read More Video Rob Bennett 27/07/2023 Video Rob Bennett 27/07/2023 Oxford Cannabinoid Technologies "officially on the way" after first dosing Read More Video Rob Bennett 19/07/2023 Video Rob Bennett 19/07/2023 Clarissa Sowemimo-Coker CEO: RNS R&D expansion into medical oncology Read More Video Rob Bennett 17/05/2023 Video Rob Bennett 17/05/2023 Clarissa Sowemimo-Coker CEO: RNS MHRA clinical trial approval Read More Video Rob Bennett 12/04/2023 Video Rob Bennett 12/04/2023 Clarissa Sowemimo-Coker CEO: RNS Clarissa appointed CEO permanently plus Programme updates Read More Video Rob Bennett 08/03/2023 Video Rob Bennett 08/03/2023 Clarissa Sowemimo-Coker CEO: Update on CTA Phase 1, MHRA approval process Read More Video Rob Bennett 15/02/2023 Video Rob Bennett 15/02/2023 Premiere Event Clarissa Sowemimo-Coker CEO Read More Video Rob Bennett 23/01/2023 Video Rob Bennett 23/01/2023 Clarissa Sowemimo-Coker CEO: Report strong results in their half-year report Read More Video Rob Bennett 23/01/2023 Video Rob Bennett 23/01/2023 Investor Meet Company -OCT Results and Company Update Read More Video Rob Bennett 06/01/2023 Video Rob Bennett 06/01/2023 Dr Valentino Parravicini: Oxford Cannabinoid Submit Clinical Trial Application Read More Video Rob Bennett 06/01/2023 Video Rob Bennett 06/01/2023 Oxford Cannabinoid Technologies "ready to go" after phase 1 trial submission Read More Video Rob Bennett 14/11/2022 Video Rob Bennett 14/11/2022 Oxford Cannabinoid Technologies nearly ready for new Phase 1 trial Read More Older Posts
Article, Video Rob Bennett 16/08/2024 Article, Video Rob Bennett 16/08/2024 09/05 OCT Reveal Plans to Delist as Stocks Struggle Read More
Video Rob Bennett 01/12/2023 Video Rob Bennett 01/12/2023 Oxford Cannabinoid Technologies Appoint Dr Tim Corn, CMO as Exec. Director Read More
Article, Video Rob Bennett 20/11/2023 Article, Video Rob Bennett 20/11/2023 Oxford Cannabinoid Technologies strengthens board with CMO Dr. Tim Corn Read More
Article, Video Rob Bennett 31/10/2023 Article, Video Rob Bennett 31/10/2023 Oxford Cannabinoid Technologies – executive interview Read More
Article, Video Rob Bennett 10/10/2023 Article, Video Rob Bennett 10/10/2023 Oxford Cannabinoid Technologies CEO says objective "absolutely met" in lead asset trial Read More
Video, Article Rob Bennett 25/09/2023 Video, Article Rob Bennett 25/09/2023 Oxford Cannabinoid Technologies reports no adverse events in OCT461201 trial Read More
Video Rob Bennett 25/09/2023 Video Rob Bennett 25/09/2023 Oxford Canabinoid Tech. Complete Phase 1 Clinical Trials on Programme 1 for CIPN Treatment Read More
Video Rob Bennett 20/08/2023 Video Rob Bennett 20/08/2023 OCT features on Research Talks with Alan Green Read More
Video Rob Bennett 27/07/2023 Video Rob Bennett 27/07/2023 Clarissa Sowemimo-Coker CEO: OCTP Achieves Milestone in Phase One Clinical Trial Read More
Video Rob Bennett 27/07/2023 Video Rob Bennett 27/07/2023 Oxford Cannabinoid Technologies "officially on the way" after first dosing Read More
Video Rob Bennett 19/07/2023 Video Rob Bennett 19/07/2023 Clarissa Sowemimo-Coker CEO: RNS R&D expansion into medical oncology Read More
Video Rob Bennett 17/05/2023 Video Rob Bennett 17/05/2023 Clarissa Sowemimo-Coker CEO: RNS MHRA clinical trial approval Read More
Video Rob Bennett 12/04/2023 Video Rob Bennett 12/04/2023 Clarissa Sowemimo-Coker CEO: RNS Clarissa appointed CEO permanently plus Programme updates Read More
Video Rob Bennett 08/03/2023 Video Rob Bennett 08/03/2023 Clarissa Sowemimo-Coker CEO: Update on CTA Phase 1, MHRA approval process Read More
Video Rob Bennett 15/02/2023 Video Rob Bennett 15/02/2023 Premiere Event Clarissa Sowemimo-Coker CEO Read More
Video Rob Bennett 23/01/2023 Video Rob Bennett 23/01/2023 Clarissa Sowemimo-Coker CEO: Report strong results in their half-year report Read More
Video Rob Bennett 23/01/2023 Video Rob Bennett 23/01/2023 Investor Meet Company -OCT Results and Company Update Read More
Video Rob Bennett 06/01/2023 Video Rob Bennett 06/01/2023 Dr Valentino Parravicini: Oxford Cannabinoid Submit Clinical Trial Application Read More
Video Rob Bennett 06/01/2023 Video Rob Bennett 06/01/2023 Oxford Cannabinoid Technologies "ready to go" after phase 1 trial submission Read More
Video Rob Bennett 14/11/2022 Video Rob Bennett 14/11/2022 Oxford Cannabinoid Technologies nearly ready for new Phase 1 trial Read More
